FDA Approves FLUDEOXYGLUCOSE F 18 — PETNET Solutions, Inc.

PETNET Solutions, Inc. has received new approval for the ANDA079086 for Fludeoxyglucose F-18, a move that bolsters the company’s portfolio of PET imaging agents and strengthens its competitive negotiation position in the radioactive pharmaceutical market. The approval supports the supply chain for critical oncology diagnostic tracers, allowing PETNET to leverage its distribution network to meet rising clinical demand amidst a fluctuating healthcare landscape.